Potent inhibition of macrophage migration inhibitory factor (MIF) by myeloperoxidase-dependent oxidation of epicatechins

Biochemical Journal

Volumn 462, Issue 2, 2014, Pages 303-314

  Dickerhof, Nina ^a   Magon, Nicholas J ^a   Tyndall, Joel D A ^b   Kettle, Anthony J ^a   Hampton, Mark B ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Dopachrome tautomerase; Epicatechin; Inflammation; Macrophage migration inhibitory factor (MIF); Myeloperoxidase (MPO)

Indexed keywords

ANTI-INFLAMMATORY AGENTS; CATECHIN; COMPUTER SIMULATION; HUMANS; HYDROGEN PEROXIDE; ISOMERISM; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MODELS, MOLECULAR; OXIDATION-REDUCTION; PERIODIC ACID; PEROXIDASE; RECOMBINANT PROTEINS;

EID: 84905906541     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20140612     Document Type: Article

References (80)

1. David, J. R. (1966) Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc. Natl. Acad. Sci. U.S.A. 56, 72-77
2. Bloom, B. R. and Bennett, B. (1966) Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153, 80-82
3. Baumann, R., Casaulta, C., Simon, D., Conus, S., Yousefi, S. and Simon, H. U. (2003) Macrophage migration inhibitory factor delays apoptosis in neutrophils by inhibiting the mitochondria-dependent death pathway. FASEB J. 17, 2221-2230 (Pubitemid 37509578)
4. Riedemann, N. C., Guo, R. F., Gao, H., Sun, L., Hoesel, M., Hollmann, T. J., Wetsel, R. A., Zetoune, F. S. and Ward, P. A. (2004) Regulatory role of C5a on macrophage migration inhibitory factor release from neutrophils. J. Immunol. 173, 1355-1359 (Pubitemid 38924315)
5. Daryadel, A., Grifone, R. F., Simon, H. U. and Yousefi, S. (2006) Apoptotic neutrophils release macrophage migration inhibitory factor upon stimulation with tumor necrosis factor- J. Biol. Chem. 281, 27653-27661 (Pubitemid 44401790)
6. Rossi, A. G., Haslett, C., Hirani, N., Greening, A. P., Rahman, I., Metz, C. N., Bucala, R. and Donnelly, S. C. (1998) Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma. J. Clin. Invest. 101, 2869-2874 (Pubitemid 28294596)
7. Calandra, T., Bernhagen, J., Mitchell, R. A. and Bucala, R. (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med. 179, 1895-1902 (Pubitemid 24155670)
8. Calandra, T. and Roger, T. (2003) Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol. 3, 791-800 (Pubitemid 37328657)
9. Mitchell, R. A., Liao, H., Chesney, J., Fingerle-Rowson, G., Baugh, J., David, J. and Bucala, R. (2002) Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc. Natl. Acad. Sci. U.S.A. 99, 345-350 (Pubitemid 34060365)
10. Hudson, J. D., Shoaibi, M. A., Maestro, R., Carnero, A., Hannon, G. J. and Beach, D. H. (1999) A proinflammatory cytokine inhibits p53 tumor suppressor activity. J. Exp. Med. 190, 1375-1382
11. Lolis, E. (2001) Glucocorticoid counter regulation: macrophage migration inhibitory factor as a target for drug discovery. Curr. Opin. Pharmacol. 1, 662-668 (Pubitemid 33586010)
12. Mitchell, R. A., Metz, C. N., Peng, T. and Bucala, R. (1999) Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action. J. Biol. Chem. 274, 18100-18106
13. Morand, E. F., Leech, M. and Bernhagen, J. (2006) MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nat. Rev. Drug Discov. 5, 399-410
14. Orita, M., Yamamoto, S., Katayama, N. and Fujita, S. (2002) Macrophage migration inhibitory factor and the discovery of tautomerase inhibitors. Curr. Pharm. Des. 8, 1297-1317 (Pubitemid 34594254)
15. Sanchez, E., Gomez, L. M., Lopez-Nevot, M. A., Gonzalez-Gay, M. A., Sabio, J. M., Ortego-Centeno, N., de Ramon, E., Anaya, J. M., Gonzalez-Escribano, M. F., Koeleman, B. P. and Martin, J. (2006) Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus. Genes Immun. 7, 433-436 (Pubitemid 44111648)
16. Miller, E. J., Li, J., Leng, L., McDonald, C., Atsumi, T., Bucala, R. and Young, L. H. (2008) Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart. Nature 451, 578-582 (Pubitemid 351186266)
17. Arjona, A., Foellmer, H. G., Town, T., Leng, L., McDonald, C., Wang, T., Wong, S. J., Montgomery, R. R., Fikrig, E. and Bucala, R. (2007) Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion. J. Clin. Invest. 117, 3059-3066 (Pubitemid 47529635)
18. Koebernick, H., Grode, L., David, J. R., Rohde, W., Rolph, M. S., Mittrucker, H. W. and Kaufmann, S. H. (2002) Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium. Proc. Natl. Acad. Sci. U.S.A. 99, 13681-13686 (Pubitemid 35215441)
19. Bozza, M., Satoskar, A. R., Lin, G., Lu, B., Humbles, A. A., Gerard, C. and David, J. R. (1999) Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J. Exp. Med. 189, 341-346 (Pubitemid 29063255)
20. Calandra, T., Echtenacher, B., Roy, D. L., Pugin, J., Metz, C. N., Hultner, L., Heumann, D., Mannel, D., Bucala, R. and Glauser, M. P. (2000) Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat. Med. 6, 164-170 (Pubitemid 30082360)
21. Bernhagen, J., Calandra, T., Mitchell, R. A., Martin, S. B., Tracey, K. J., Voelter, W., Manogue, K. R., Cerami, A. and Bucala, R. (1993) MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365, 756-759 (Pubitemid 23339882)
22. Winner, M., Meier, J., Zierow, S., Rendon, B. E., Crichlow, G. V., Riggs, R., Bucala, R., Leng, L., Smith, N., Lolis, E. et al. (2008) A novel, macrophage migration inhibitory factor suicide substrate inhibits motility and growth of lung cancer cells. Cancer Res. 68, 7253-7257
23. Leng, L., Metz, C. N., Fang, Y., Xu, J., Donnelly, S., Baugh, J., Delohery, T., Chen, Y., Mitchell, R. A. and Bucala, R. (2003) MIF signal transduction initiated by binding to CD74. J. Exp. Med. 197, 1467-1476 (Pubitemid 36686708)
24. Shi, X., Leng, L., Wang, T., Wang, W., Du, X., Li, J., McDonald, C., Chen, Z., Murphy, J. W., Lolis, E. et al. (2006) CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 25, 595-606 (Pubitemid 44529040)
25. Gore, Y., Starlets, D., Maharshak, N., Becker-Herman, S., Kaneyuki, U., Leng, L., Bucala, R. and Shachar, I. (2008) Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex. J. Biol. Chem. 283, 2784-2792
26. Rosengren, E., Aman, P., Thelin, S., Hansson, C., Ahlfors, S., Bjork, P., Jacobsson, L. and Rorsman, H. (1997) The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase. FEBS Lett. 417, 85-88 (Pubitemid 27490478)
27. Bendrat, K., Al-Abed, Y., Callaway, D. J., Peng, T., Calandra, T., Metz, C. N. and Bucala, R. (1997) Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor. Biochemistry 36, 15356-15362 (Pubitemid 27528002)
28. Swope, M., Sun, H. W., Blake, P. R. and Lolis, E. (1998) Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor. EMBO J. 17, 3534-3541 (Pubitemid 28327372)
29. Ouertatani-Sakouhi, H., El-Turk, F., Fauvet, B., Roger, T., Le Roy, D., Karpinar, D. P., Leng, L., Bucala, R., Zweckstetter, M., Calandra, T. and Lashuel, H. A. (2009) A new class of isothiocyanate-based irreversible inhibitors of macrophage migration inhibitory factor. Biochemistry 48, 9858-9870
30. Senter, P. D., Al-Abed, Y., Metz, C. N., Benigni, F., Mitchell, R. A., Chesney, J., Han, J., Gartner, C. G., Nelson, S. D., Todaro, G. J. and Bucala, R. (2002) Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites. Proc. Natl. Acad. Sci. U.S.A. 99, 144-149 (Pubitemid 34060331)
31. Fingerle-Rowson, G., Kaleswarapu, D. R., Schlander, C., Kabgani, N., Brocks, T., Reinart, N., Busch, R., Schutz, A., Lue, H., Du, X. et al. (2009) A tautomerase-null macrophage migration-inhibitory factor (MIF) gene knock-in mouse model reveals that protein interactions and not enzymatic activity mediate MIF-dependent growth regulation. Mol. Cell. Biol. 29, 1922-1932
32. Lubetsky, J. B., Dios, A., Han, J., Aljabari, B., Ruzsicska, B., Mitchell, R., Lolis, E. and Al-Abed, Y. (2002) The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents. J. Biol. Chem. 277, 24976-24982 (Pubitemid 34951799)
33. Dios, A., Mitchell, R. A., Aljabari, B., Lubetsky, J., O'Connor, K., Liao, H., Senter, P. D., Manogue, K. R., Lolis, E., Metz, C. et al. (2002) Inhibition of MIF bioactivity by rational design of pharmacological inhibitors of MIF tautomerase activity. J. Med. Chem. 45, 2410-2416 (Pubitemid 34595211)
34. Dagia, N. M., Kamath, D. V., Bhatt, P., Gupte, R. D., Dadarkar, S. S., Fonseca, L., Agarwal, G., Chetrapal-Kunwar, A., Balachandran, S., Srinivasan, S. et al. (2009) A fluorinated analog of ISO-1 blocks the recognition and biological function of MIF and is orally efficacious in a murine model of colitis. Eur. J. Pharmacol. 607, 201-212
35. Brown, K. K., Blaikie, F. H., Smith, R. A., Tyndall, J. D., Lue, H., Bernhagen, J., Winterbourn, C. C. and Hampton, M. B. (2009) Direct modification of the proinflammatory cytokine macrophage migration inhibitory factor by dietary isothiocyanates. J. Biol. Chem. 284, 32425-32433
36. Aron, P. M. and Kennedy, J. A. (2008) Flavan-3-ols: nature, occurrence and biological activity. Mol. Nutr. Food. Res. 52, 79-104 (Pubitemid 351211804)
37. Balentine, D. A., Wiseman, S. A. and Bouwens, L. C. (1997) The chemistry of tea flavonoids. Crit. Rev. Food Sci. Nutr. 37, 693-704 (Pubitemid 127349613)
38. Bunton, C. A. and Shiner, V. J. (1960) Periodate oxidation of 1,2-diols, diketones, and hydroxy-ketones: the use of oxygen-18 as a tracer. J. Chem. Soc. 1593-1598
39. Munoz-Munoz, J. L., Garcia-Molina, F., Molina-Alarcon, M., Tudela, J., Garcia-Canovas, F. and Rodriguez-Lopez, J. N. (2008) Kinetic characterization of the enzymatic and chemical oxidation of the catechins in green tea. J. Agric. Food Chem. 56, 9215-9224
40. Kettle, A. J. and Winterbourn, C. C. (1992) Oxidation of hydroquinone by myeloperoxidase. Mechanism of stimulation by benzoquinone. J. Biol. Chem. 267, 8319-8324
41. Meotti, F. C., Senthilmohan, R., Harwood, D. T., Missau, F. C., Pizzolatti, M. G. and Kettle, A. J. (2008) Myricitrin as a substrate and inhibitor of myeloperoxidase: implications for the pharmacological effects of flavonoids. Free Radic. Biol. Med. 44, 109-120 (Pubitemid 350138636)
42. Spalteholz, H., Furtmuller, P. G., Jakopitsch, C., Obinger, C., Schewe, T., Sies, H. and Arnhold, J. (2008) Kinetic evidence for rapid oxidation of (-)-epicatechin by human myeloperoxidase. Biochem. Biophys. Res. Commun. 371, 810-813
43. Winterbourn, C. C., Vissers, M. C. and Kettle, A. J. (2000) Myeloperoxidase. Curr. Opin. Hematol. 7, 53-58 (Pubitemid 30007688)
44. Nicholls, S. J. and Hazen, S. L. (2005) Myeloperoxidase and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 25, 1102-1111 (Pubitemid 40776595)
45. Kettle, A. J. and Winterbourn, C. C. (1997) Myeloperoxidase: a key regulator of neutrophil oxidant production. Redox Rep. 3, 3-15 (Pubitemid 27199160)
46. van Dalen, C. J., Whitehouse, M. W., Winterbourn, C. C. and Kettle, A. J. (1997) Thiocyanate and chloride as competing substrates for myeloperoxidase. Biochem. J. 327, 487-492 (Pubitemid 27477827)
47. Furtmuller, P. G., Zederbauer, M., Jantschko, W., Helm, J., Bogner, M., Jakopitsch, C. and Obinger, C. (2006) Active site structure and catalytic mechanisms of human peroxidases. Arch. Biochem. Biophys. 445, 199-213 (Pubitemid 43082213)
48. Marquez, L. A. and Dunford, H. B. (1995) Kinetics of oxidation of tyrosine and dityrosine by myeloperoxidase compounds I and II. Implications for lipoprotein peroxidation studies. J. Biol. Chem. 270, 30434-30440
49. Burner, U., Jantschko, W. and Obinger, C. (1999) Kinetics of oxidation of aliphatic and aromatic thiols by myeloperoxidase compounds I and II. FEBS Lett. 443, 290-296 (Pubitemid 29080813)
50. Burner, U., Furtmuller, P. G., Kettle, A. J., Koppenol, W. H. and Obinger, C. (2000) Mechanism of reaction of myeloperoxidase with nitrite. J. Biol. Chem. 275, 20597-20601 (Pubitemid 30457644)
51. Jantschko, W., Furtmuller, P. G., Allegra, M., Livrea, M. A., Jakopitsch, C., Regelsberger, G. and Obinger, C. (2002) Redox intermediates of plant and mammalian peroxidases: a comparative transient-kinetic study of their reactivity toward indole derivatives. Arch. Biochem. Biophys. 398, 12-22 (Pubitemid 34848320)
52. Meotti, F. C., Jameson, G. N., Turner, R., Harwood, D. T., Stockwell, S., Rees, M. D., Thomas, S. R. and Kettle, A. J. (2011) Urate as a physiological substrate for myeloperoxidase: implications for hyperuricemia and inflammation. J. Biol. Chem. 286, 12901-12911
53. Beers, Jr, R. F. and Sizer, I. W. (1952) A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J. Biol. Chem. 195, 133-140
54. Odajima, T. and Yamazaki, I. (1970) Myeloperoxidase of leukocyte of normal blood. 1. Reaction of myeloperoxidase with hydrogen peroxide. Biochim. Biophys. Acta 206, 71-77
55. Aroca, P., Solano, F., Garcia-Borron, J. C. and Lozano, J. A. (1991) Specificity of dopachrome tautomerase and inhibition by carboxylated indoles. Considerations on the enzyme active site. Biochem. J. 277, 393-397
56. Harrison, J. E. and Schultz, J. (1976) Studies on the chlorinating activity of myeloperoxidase. J. Biol. Chem. 251, 1371-1374
57. Cren-Olive, C., Deprez, S., Lebrun, S., Coddeville, B. and Rolando, C. (2000) Characterization of methylation site of monomethylflavan-3-ols by liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom. 14, 2312-2319
58. Klebanoff, S. J., Kettle, A. J., Rosen, H., Winterbourn, C. C. and Nauseef, W. M. (2013) Myeloperoxidase: a front-line defender against phagocytosed microorganisms. J. Leukoc. Biol. 93, 185-198
59. Amulic, B., Cazalet, C., Hayes, G. L., Metzler, K. D. and Zychlinsky, A. (2012) Neutrophil function: from mechanisms to disease. Annu. Rev. Immunol. 30, 459-489
60. Ximenes, V. F., Maghzal, G. J., Turner, R., Kato, Y., Winterbourn, C. C. and Kettle, A. J. (2010) Serotonin as a physiological substrate for myeloperoxidase and its superoxide-dependent oxidation to cytotoxic tryptamine-4,5-dione. Biochem. J. 425, 285-293
61. Marquez, L. A., Dunford, H. B. and Van Wart, H. (1990) Kinetic studies on the reaction of compound II of myeloperoxidase with ascorbic acid. Role of ascorbic acid in myeloperoxidase function. J. Biol. Chem. 265, 5666-5670
62. Lee, M. J., Wang, Z. Y., Li, H., Chen, L., Sun, Y., Gobbo, S., Balentine, D. A. and Yang, C. S. (1995) Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol. Biomarkers Prev. 4, 393-399
63. Ottaviani, J. I., Momma, T. Y., Kuhnle, G. K., Keen, C. L. and Schroeter, H. (2012) Structurally related (-)-epicatechin metabolites in humans: assessment using de novo chemically synthesized authentic standards. Free Radic. Biol. Med. 52, 1403-1412
64. Rein, D., Lotito, S., Holt, R. R., Keen, C. L., Schmitz, H. H. and Fraga, C. G. (2000) Epicatechin in human plasma: in vivo determination and effect of chocolate consumption on plasma oxidation status. J. Nutr. 130, 2109S-2114S (Pubitemid 30619391)
65. Yang, C. S., Chen, L., Lee, M. J., Balentine, D., Kuo, M. C. and Schantz, S. P. (1998) Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol. Biomarkers Prev. 7, 351-354 (Pubitemid 28354149)
66. Radstake, T. R., Sweep, F. C., Welsing, P., Franke, B., Vermeulen, S. H., Geurts-Moespot, A., Calandra, T., Donn, R. and van Riel, P. L. (2005) Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum. 52, 3020-3029 (Pubitemid 41447081)
67. Nishihira, J. and Mitsuyama, K. (2009) Overview of the role of macrophage migration inhibitory factor (MIF) in inflammatory bowel disease. Curr. Pharm. Des. 15, 2104-2109
68. Young, D. A., Young, E., Roux, D. G., Brandt, E. V. and Ferreira, D. (1987) Synthesis of condensed tannins. 19. Phenol oxidative coupling of (+)-catechin and (+)-mesquitol: conformation of Bis-(+)-catechins. J. Chem. Soc. Perk. T. 1, 2345-2351
69. Guyot, S., Cheynier, V., Souquet, J. M. and Moutounet, M. (1995) Influence of Ph on the enzymatic oxidation of (+)-catechin in model systems. J. Agric. Food Chem. 43, 2458-2462
70. Szewczuk, L. M. and Penning, T. M. (2004) Mechanism-based inactivation of COX-1 by red wine m-hydroquinones: a structure-activity relationship study. J. Nat. Prod. 67, 1777-1782 (Pubitemid 39602350)
71. D'Alessandro, T., Prasain, J., Benton, M. R., Botting, N., Moore, R., Darley-Usmar, V., Patel, R. and Barnes, S. (2003) Polyphenols, inflammatory response, and cancer prevention: chlorination of isoflavones by human neutrophils. J. Nutr. 133, 3773S-3777S (Pubitemid 37392599)
72. Mori, T., Ishii, T., Akagawa, M., Nakamura, Y. and Nakayama, T. (2010) Covalent binding of tea catechins to protein thiols: the relationship between stability and electrophilic reactivity. Biosci. Biotechnol. Biochem. 74, 2451-2456
73. Ishii, T., Mori, T., Ichikawa, T., Kaku, M., Kusaka, K., Uekusa, Y., Akagawa, M., Aihara, Y., Furuta, T., Wakimoto, T. et al. (2010) Structural characteristics of green tea catechins for formation of protein carbonyl in human serum albumin. Bioorg. Med. Chem. 18, 4892-4896
74. Ishii, T., Ichikawa, T., Minoda, K., Kusaka, K., Ito, S., Suzuki, Y., Akagawa, M., Mochizuki, K., Goda, T. and Nakayama, T. (2011) Human serum albumin as an antioxidant in the oxidation of (-)-epigallocatechin gallate: participation of reversible covalent binding for interaction and stabilization. Biosci. Biotechnol. Biochem. 75, 100-106
75. Babu, P. V. and Liu, D. (2008) Green tea catechins and cardiovascular health: an update. Curr. Med. Chem. 15, 1840-1850
76. Higdon, J. V. and Frei, B. (2003) Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit. Rev. Food Sci. Nutr. 43, 89-143 (Pubitemid 38552312)
77. Khan, N. and Mukhtar, H. (2007) Tea polyphenols for health promotion. Life Sci. 81, 519-533 (Pubitemid 47212236)
78. Riegsecker, S., Wiczynski, D., Kaplan, M. J. and Ahmed, S. (2013) Potential benefits of green tea polyphenol EGCG in the prevention and treatment of vascular inflammation in rheumatoid arthritis. Life Sci. 93, 307-312
79. Hou, Z., Sang, S. M., You, H., Lee, M. J., Hong, J., Chin, K. V. and Yang, C. S. (2005) Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells. Cancer Res. 65, 8049-8056 (Pubitemid 41297287)
80. Yao, H., Xu, W., Shi, X. and Zhang, Z. (2011) Dietary flavonoids as cancer prevention agents. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 29, 1-31